Abstract
People with end-stage renal disease (ESRD) caused by diabetes account for 29.4% of people on maintenance haemodialysis (MHDx). When taking into account those with diabetes not causing ESRD, this figure rises up to 40% in some units.1 People with diabetes and kidney disease are at a particularly high risk of complications such as non-traumatic lower extremity amputation, cardiovascular events and death, with overall survival on MHDx in people with diabetes being approximately half that of their non-diabetic peers (3.7 vs 7.0 years).2–4 In 2016, guidelines were published by the Joint British Diabetes Societies in conjunction with the Renal Association, aimed at …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
